AiCure

Global News

Bracket releases Rater Station 3.5

Thursday, November 13, 2014 08:00 AM

Bracket, a global specialty service provider, has released Rater Station 3.5, a core technology platform. Rater Station 3.5 offers the advantages of a single system for management of clinical trial data collection and advanced Endpoint Reliability solutions.

More... »


Dendreon files for bankruptcy protection

Wednesday, November 12, 2014 03:30 PM

Dendreon, a Seattle-based biotechnology company, and its U.S. subsidiaries filed voluntary petitions under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware on Nov. 10.

More... »


Clinerion launches real-time patient recruitment system to boost trial recruitment

Wednesday, November 12, 2014 03:27 PM

Clinerion, a Swiss-based software and services company, has launched its Patient Recruitment System (PRS). Clinerion’s PRS radically boosts recruitment for clinical trials, identifying 10 to 30 times more suitable candidates than those found through a classical manual screening approach, and in a matter of minutes rather than the weeks or months typically needed.

More... »

Qiagen inks ninth master collaboration agreement for companion diagnostics

Wednesday, November 12, 2014 03:26 PM

Qiagen, a Netherlands-based holding company, has entered into a master collaboration agreement with the Swiss pharmaceutical company Novartis to enable the development and commercialization of companion diagnostics to be paired with existing Novartis pharmaceutical products as well as compounds in its development pipeline.

More... »

Consort Medical acquires Aesica

Wednesday, November 12, 2014 03:26 PM

Consort has completed its acquisition of Aesica Holdco. The acquisition is directly in line with Consort's articulated strategy of diversifying into adjacent markets and technologies to capture additional value in the drug/device supply chain.

More... »

Coté Orphan launches CRO to simplify orphan drug developement process

Wednesday, November 12, 2014 03:22 PM

Coté Orphan, a regulatory affairs advisory firm based in Silver Spring, Md., has added a new line of service for its clients by providing CRO services that will help organizations navigate the clinical trials process through the lens of regulatory affairs. With the addition of the CRO services, Coté Orphan provides companies a complete and robust solution to those developing or seeking to develop orphan drugs.

More... »

Report: Big biopharma would rather ‘make than buy’

Wednesday, November 12, 2014 03:21 PM

Global and generic biopharma companies will continue to prefer in-house manufacturing to outsourcing for the most strategic elements of their businesses, according to a report by PharmSource Information Services, a Virginia-based provider of market intelligence for the global contract biopharma industry.

More... »

INC Research launches its IPO

Monday, November 10, 2014 02:38 PM

Global CRO INC Research launched its initial public offering today, raising $150 million by selling just over 8.1 million shares at $18.50 per share—the middle of the expected $17-$20 range. The stock climbed 9% in early trading past $20.75 before settling to $20 by late afternoon.

More... »

Felicitex Therapeutics, Selvita collaborate to target cancer quiescence

Monday, November 10, 2014 12:18 PM

Cambridge, Mass.-based Felicitex Therapeutics, a privately owned drug discovery company, and Selvita, a Polish biotechnology company, have entered into a strategic collaboration to develop breakthrough personalized cancer therapeutics for some of the deadliest and most resistant cancers, such as pancreatic, colon, ovarian, lung and hematopoietic tumors.

More... »

Study: CNS drugs have lower regulatory success rate, take longer to develop

Monday, November 10, 2014 12:02 PM

Developing drugs to treat a wide array of central nervous systems disorders—including depression, psychosis, epilepsy and Alzheimer’s disease—takes longer and has an overall success rate of less than half that of other types of drug candidates.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 17

PPD, Medidata join their technologies for risk-based monitoring, adaptive trial design

ERT acquires eClinical Insights in "strategic combination" to gain cloud-based trial software platform, expertise

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs